Wichita County Defective Breast Mesh & Implant Injury Attorneys: Attorney911 (The Manginello Law Firm, PLLC) Couples Ralph Manginello’s 27+ Years of Federal-Court Trial Experience with Lupe Peña’s Inside Knowledge as a Former Insurance Defense Attorney. We Represent Wichita County Patients Injured by AlloDerm, Strattice, and GalaFLEX P4HB Scaffolds or Diagnosed with BIA-ALCL (CD30+/ALK-) and BIA-SCC from Recalled Allergan BIOCELL Textured Implants. $50M+ Recovered, Current $10M Bermudez Litigation Prosecution, and Substantive Mastery of 21 CFR Parts 803, 807, 814 and the Riegel Parallel-Claim Exception. Our Firm Handles Wichita County’s MDL 2921 Claims Before Judge Brian R. Martinotti with Bellwether October 19, 2026, Applying the Texas 2-Year Statute of Limitations (CPRC § 16.003) and Discovery Rule. Free 24/7 Consultation, No Fee Unless We Recover Compensation for You, Hablamos Español, 1-888-ATTY-911.
Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Wichita County: The Complete Guide for Women and Families We recognize that for many women in Wichita County, the road to breast reconstruction or elective augmentation is paved with a desire for healing, wholeness, and health. Whether you were seeking to reclaim your body after a diagnosis at a facility like United Regional Health Care System in Wichita Falls or you chose a procedure to enhance your confidence at a specialist center in the North Texas region, you placed your trust in the medical device industry. You trusted that the products implanted in your chest—the surgical meshes, the acellular dermal matrices (ADM), and the bioabsorbable scaffolds—had been rigorously tested, approved, and proven safe for use in human breast tissue. The reality, as we have uncovered through years of litigation and deep regulatory analysis, is far more troubling. Many of the products frequently used in Wichita County operating rooms were never actually "approved" by the FDA for use in breast surgery. They entered the market through a regulatory loophole known as the 510(k) clearance pathway—a shortcut that allowed manufacturers to sell devices without conducting a single human clinical trial…